Skip to main content
IMS Events Main banner
Back

    Meletios A. Dimopoulos, MD

    Professor and Chairman of the Department of Clinical Therapeutics
    National and Kapodistrian University of Athens, Greece

    Meletios A. Dimopoulos, MD is Professor and Chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine, Athens, Greece. He was the Rector of the National and Kapodistrian University of Athens from February 2015 until August 2023. He has been a member of the Board of the International Myeloma Society and the chairman of the Greek Myeloma Study Group. Currently he is the chairman of the Balkan Myeloma Study Group, a member of the Board of the European Myeloma Network and a member of the scientific committee of the European School of Haematology.
    He has published more than 1400 (1427, 19.6.2024) papers and his h-index (ISI) is 136 with the particular interest in hematologic malignancies (especially plasma cell dyscracias) and solid tumors.
    He is a recipient of the Robert A. Kyle Award for outstanding contributions to Waldenstrom’s macroglobulinemia (May 2003), a recipient of Waldenstrom's award for Myeloma Research of the International Myeloma Society (March 2017), recipient of the CoMy Excellence Award (May 2017). In August 2017 he was given the title "Officier dans l' Ordre des Palmes academiques" (Republique Francaise, Ministere de l' Education Nationale). In May 2018 he was elected as “membre associe etranger” of the National Academy of Medecine of France. He also received The Robert Kyle Life Achievement Award (June 2019), Distinguished Alumnus Award from the MD Anderson Cancer Centre, Houston, TX, USA (January 2020), Medal of the Grand Commander of the Order of the Phoenix awarded by the President of the Hellenic Republic (February 2020) and the Title of Doctor Honoris Causa by the University of Belgrade (October 2022).





    Disclosure information not submitted.

    Presentation(s):